Predictive Factors for 24 Weeks Sustained Virologic Response (SVR24) and Viral Relapse in Patients Treated With Simeprevir Plus Peginterferon and Ribavirin

Hepatology International - India
doi 10.1007/s12072-015-9654-9
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Characterization of Nonrapid Virologic Response Patients Infected With HCV Genotype 1 Who May Relapse After Standard Therapy With Peginterferon Plus Ribavirin

Journal of Viral Hepatitis
VirologyHepatologyInfectious Diseases
2011English

Low Rates of Sustained Virologic Response With Peginterferon Plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV Infected Patients in Rio De Janeiro, Brazil

PLoS ONE
Multidisciplinary
2013English

An Hepatitis C Virus (HCV)/HIV Co-Infected Patient Who Developed Severe Hepatitis During Chronic HCV Infection: Sustained Viral Response With Simeprevir Plus Peginterferon-Alpha and Ribavirin

Internal Medicine
Internal MedicineMedicine
2015English

Randomized Trial of Peginterferon Alfa-2b and Ribavirin for 48 or 72 Weeks in Patients With Hepatitis C Virus Genotype 1 and Slow Virologic Response

Hepatology
MedicineHepatology
2010English

Sustained Virologic Response and IL28B Single-Nucleotide Polymorphisms in Patients With Chronic Hepatitis C Treated With Pegylated Interferon Alfa and Ribavirin.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin for 24 Weeks in Patients With HCV GT4 and Compensated Cirrhosis (AGATE-I Part II)

Health Science Reports
2019English

Prediction of Sustained Virological Response to Telaprevir/Simeprevir-Based Triple Therapy in Patients With Genotype 1 Hepatitis C Virus Using Super-Early Viral Response Within 2 Weeks

Journal of Liver
2017English

Peginterferon Alfa-2a Is Associated With Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients With Sustained Virologic Response

PLoS ONE
Multidisciplinary
2014English

Incidence of and Risk Factors for Thyroid Dysfunction During Peginterferon Α and Ribavirin Treatment in Patients With Chronic Hepatitis C

Korean Journal of Internal Medicine
Internal Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy